ARMISTICE CAPITAL, LLC

Q1 2025 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
3/31/2025
Date filed
5/15/2025
Form type
13F-HR
Num holdings
230
Total value ($000)
$6,672,407
Net value change ($000)
-657,579 (-9.0%)
New positions
64
Sold out positions
59
Turnover %
23.4%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 2/14/2025 Next filing: 8/14/2025 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q4 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
FRPT 59,630 NEW
REGN 52,372 262.2%
SNN 38,044 313.3%
KDP 37,632 NEW
STAA 31,709 149.7%
TVTX 30,810 24.0%
MRK 29,086 NEW
AVNS 28,660 NEW
DPZ 20,452 97.7%
HELE 19,845 NEW
Top Reduces (Value $000, Stocks/ETFs)
Inari Medical, Inc. -79,923 -100.0%
ICLR -70,174 -80.0%
BUD -68,045 -100.0%
VRTX -65,970 -73.1%
GSK -65,780 -81.8%
HUM -64,334 -81.3%
NVO -53,746 -87.8%
SNY -31,130 -51.7%
MNST -29,929 -100.0%
SBUX -29,211 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 2,930,352 (43.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None